HMA Strategic Plan on antimicrobial issues

Antimicrobial resistance (AMR) is considered to be a major global public health concern and a potential food safety issue.  In the area of veterinary medicine, this issue needs to be considered both from a human health perspective and from the perspective of protection of animal health and welfare and the environment.

Resistance in bacterial species can cause difficulties in the treatment of both the life threatening and serious, injurious infections in humans and animals.

The concerns related to AMR have been discussed by the HMA as a result of which a strategic plan was prepared on veterinary medicine related antimicrobial issues.  The objective for this strategic plan is to identify areas where HMA has responsibility to catalyse, facilitate and directly implement activities within the EU and intentify those areas where involvement of HMA with other parties would be beneficial.

The HMA strategic plan on antimicrobial issues provides the HMA with a vision with respect to AMR.  In addition to the HMA vision, the HMA Strategic plan defines the relative responsibilities of both Nation Competent Authorities (NCAs) and of HMA acting collectively.  Concrete steps/actions to be taken by the HMA and NCAs are outlined in the HMA Action plan.

• HMA Strategic Plan on antimicrobial issues
  Agreed June 2010
  Click here

• HMA Action Plan on antimicrobial issues
  Revised and Adopted HMA November 2011
  Click here

01/01/70

National Competent Authorities (NCAs) Activities Regarding Antimicrobial Resistance

The knowledge about habits for prescription and use of antimicrobials in the EU is sparse and therefore an action from the HMA Action plan was to gain more information from NCAs on their current national activities relating to antimicrobial resistance.

This information was collated and summarised in the documents below.

• Overview of Member State and EFTA country Veterinary Regulatory Agency activities in the area of AMR (as of November 2011)
  Click here

• Summary of the veterinary antimicrobial resistance surveillance activities performed in each Member State and EFTA countries (as of November 2011)
  Click here

01/01/70

HMA EMA Meeting 'Progress in the area of Antimicrobial Resisitance - Veterianry Medicines' - 15 16 September 2011

Another step from the HMA Action plan was to look at communication and interaction with stakeholders in the Member States and at the Community level.  A number of stakeholders were identified and invited to attend a meeting to discuss 'Progress in the area of Antimicrobial Resisitance - Veterinary Medicines'.

The agenda, report of the meeting and presentations from the meeting are published below.

• HMA EMA Meeting Agenda for 15-16 September 2011
  Click here

• Report of the 'Progress in the area of Antimicrobial Resistance - Veterinary Medicines' meeting
  Click here

• Presentation - The Commission
  Click here

• Presentation - HMA
  Click here

• Presentation - EMA
  Click here

• Presentation - CVMP
  Click here

• Presentation - ESVAC
  Click here

• Presentation - EGGVP
  Click here

• Presentation - IFAH-Europe
  Click here

• Presentation - FVE
  Click here

• Presentation - Copa Cogeca
  Click here

• Presentation - EPRUMA
  Click here

• Presentation - AVC
  Click here

• Presentation Overview
  Click here

• Paper for information (PK-PD modelling by Professor P Lees
  Click here